STOCK TITAN

[Form 4] THERMO FISHER SCIENTIFIC INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO) disclosed a routine insider transaction on Form 4. Executive Vice President Gianluca Pettiti sold 400 shares of common stock on 10/24/2025 at $574.15 per share (transaction code S). After the sale, he beneficially owned 21,152.223 shares, held directly. The transaction was effected under a Rule 10b5-1 trading plan adopted on February 10, 2025.

Thermo Fisher Scientific (TMO) ha reso nota un'operazione insider di routine sul Formulario 4. Il vicepresidente esecutivo Gianluca Pettiti ha venduto 400 azioni ordinarie il 24/10/2025 a 574,15 USD per azione (codice di operazione S). Dopo la vendita, possedeva direttamente 21.152,223 azioni. La transazione è stata effettuata nell'ambito di un piano di negoziazione Rule 10b5-1 adottato il 10 febbraio 2025.

Thermo Fisher Scientific (TMO) divulgó una operación interna rutinaria en el Formulario 4. El vicepresidente ejecutivo Gianluca Pettiti vendió 400 acciones ordinarias el 24/10/2025 a 574,15 USD por acción (código de transacción S). Después de la venta, poseía de forma beneficiosa 21,152.223 acciones, directamente. La operación se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 10 de febrero de 2025.

Thermo Fisher Scientific (TMO)는 Form 4에서 일상적인 내부자 거래를 공시했습니다. 수석 부사장 Gianluca Pettiti가 2025년 10월 24일 주당 574.15달러로 보통주 400주를 매도했습니다(거래 코드 S). 매각 후 그는 직접적으로 21,152.223주를 보유했습니다. 해당 거래는 2025년 2월 10일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다.

Thermo Fisher Scientific (TMO) a divulgué une opération d'initié routinière sur le formulaire 4. Le vice-président exécutif Gianluca Pettiti a vendu 400 actions ordinaires le 24/10/2025 à 574,15 USD par action (code de transaction S). Après la vente, il détenait directement 21 152,223 actions. L'opération a été effectuée dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 10 février 2025.

Thermo Fisher Scientific (TMO) gab eine routinemäßige Insider-Transaktion auf Formular 4 bekannt. Der Executive Vice President Gianluca Pettiti verkaufte am 24.10.2025 400 Stammaktien zu 574,15 USD pro Aktie (Transaktionscode S). Nach dem Verkauf hielt er direkt 21.152,223 Stammaktien. Die Transaktion erfolgte im Rahmen eines am 10. Februar 2025 verabschiedeten 10b5-1-Handelplans.

Thermo Fisher Scientific (TMO) كشفت عن عملية داخلية روتينية في النموذج 4. قام نائب الرئيس التنفيذي Gianluca Pettiti ببيع 400 سهم من الأسهم العادية في 24/10/2025 بسعر 574.15 دولاراً للسهم الواحد (رمز المعاملة S). بعد البيع، كان يملك بشكل مستفيد 21,152.223 سهماً، بشكل مباشر. تمت المعاملة بموجب خطة تداول Rule 10b5-1 التي تم اعتمادها في 10 فبراير 2025.

Positive
  • None.
Negative
  • None.

Thermo Fisher Scientific (TMO) ha reso nota un'operazione insider di routine sul Formulario 4. Il vicepresidente esecutivo Gianluca Pettiti ha venduto 400 azioni ordinarie il 24/10/2025 a 574,15 USD per azione (codice di operazione S). Dopo la vendita, possedeva direttamente 21.152,223 azioni. La transazione è stata effettuata nell'ambito di un piano di negoziazione Rule 10b5-1 adottato il 10 febbraio 2025.

Thermo Fisher Scientific (TMO) divulgó una operación interna rutinaria en el Formulario 4. El vicepresidente ejecutivo Gianluca Pettiti vendió 400 acciones ordinarias el 24/10/2025 a 574,15 USD por acción (código de transacción S). Después de la venta, poseía de forma beneficiosa 21,152.223 acciones, directamente. La operación se realizó bajo un plan de negociación Rule 10b5-1 adoptado el 10 de febrero de 2025.

Thermo Fisher Scientific (TMO)는 Form 4에서 일상적인 내부자 거래를 공시했습니다. 수석 부사장 Gianluca Pettiti가 2025년 10월 24일 주당 574.15달러로 보통주 400주를 매도했습니다(거래 코드 S). 매각 후 그는 직접적으로 21,152.223주를 보유했습니다. 해당 거래는 2025년 2월 10일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다.

Thermo Fisher Scientific (TMO) a divulgué une opération d'initié routinière sur le formulaire 4. Le vice-président exécutif Gianluca Pettiti a vendu 400 actions ordinaires le 24/10/2025 à 574,15 USD par action (code de transaction S). Après la vente, il détenait directement 21 152,223 actions. L'opération a été effectuée dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 10 février 2025.

Thermo Fisher Scientific (TMO) gab eine routinemäßige Insider-Transaktion auf Formular 4 bekannt. Der Executive Vice President Gianluca Pettiti verkaufte am 24.10.2025 400 Stammaktien zu 574,15 USD pro Aktie (Transaktionscode S). Nach dem Verkauf hielt er direkt 21.152,223 Stammaktien. Die Transaktion erfolgte im Rahmen eines am 10. Februar 2025 verabschiedeten 10b5-1-Handelplans.

Thermo Fisher Scientific (TMO) كشفت عن عملية داخلية روتينية في النموذج 4. قام نائب الرئيس التنفيذي Gianluca Pettiti ببيع 400 سهم من الأسهم العادية في 24/10/2025 بسعر 574.15 دولاراً للسهم الواحد (رمز المعاملة S). بعد البيع، كان يملك بشكل مستفيد 21,152.223 سهماً، بشكل مباشر. تمت المعاملة بموجب خطة تداول Rule 10b5-1 التي تم اعتمادها في 10 فبراير 2025.

Thermo Fisher Scientific (TMO) 在表格4上披露了一笔例行内部交易。执行副总裁 Gianluca Pettiti 于 2025 年 10 月 24 日以每股 574.15 美元出售了 400 股普通股(交易代码 S)。出售后,他直接持有 21,152.223 股。该交易是在 2025 年 2 月 10 日通过的 Rule 10b5-1 交易计划下执行。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pettiti Gianluca

(Last) (First) (Middle)
168 THIRD AVENUE

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
10/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/24/2025 S(1) 400 D $574.15 21,152.223 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2025.
/s/ Melodie T. Morin, Attorney-in-Fact for Gianluca Pettiti 10/28/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Thermo Fisher (TMO) report in this Form 4?

An insider sale by Executive Vice President Gianluca Pettiti of 400 common shares on 10/24/2025 at $574.15 per share (code S).

Who is the reporting person in TMO’s Form 4?

Gianluca Pettiti, an Officer with the title Executive Vice President.

How many Thermo Fisher shares were sold and at what price?

400 shares were sold at $574.15 per share.

How many shares does the insider hold after the transaction?

Beneficial ownership following the transaction is 21,152.223 shares, held directly.

When did the transaction occur?

The transaction date is 10/24/2025.

Was the sale under a Rule 10b5-1 plan?

Yes. It was effected under a Rule 10b5-1 trading plan adopted on February 10, 2025.
Thermo Fishr Sci

NYSE:TMO

TMO Rankings

TMO Latest News

TMO Latest SEC Filings

TMO Stock Data

212.89B
376.95M
0.16%
91.87%
1.04%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States
WALTHAM